Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aclarion, Inc. - Common Stock (NQ:ACON)

8.597 +0.167 (+1.98%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aclarion, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Dow Jumps 600 Points; US Inflation Increases To 2.9% In December
 
Via Benzinga
Topics Economy Stocks
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
BROOMFIELD, CO - January 15, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... 
Via TheNewswire.com
Topics Regulatory Compliance
Stock Indices Finished Holiday-Shortened Week With A Bullish Rally; Two New Swing Positions
In this video, I review the overall market structure, some recent long signals, and two new swing positions for next week. 
Via Talk Markets
Topics ETFs Stocks / Equities
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
BROOMFIELD, CO - (NewMediaWire) - January 3, 2025 - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary... 
Via TheNewswire.com
Topics Regulatory Compliance
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via AB Newswire
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector 
Via News Direct
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response 
Via NewMediaWire
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Micron To $140? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
 
Via NewMediaWire
Topics Artificial Intelligence
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
ACON stock results show that Aclarion beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Aclarion Announces First Commercial Agreement in Michigan
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
Notice of Allowance is for the 23rd US Patent to be Awarded to Aclarion 
Via TheNewswire.com
Topics Intellectual Property
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine. 
Via TheNewswire.com
Topics Artificial Intelligence
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.